Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01729429 · ClinicalTrials.gov registry record · NA
An Intervention Promoting HPV Vaccination in Safety-net Clinics
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 831
- Enrollment target
NCT01729429: Completed NA study, sponsored by University of Texas Southwestern Medical Center.
NCT01729429 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 831 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01729429, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 831 participants
- Enrollment target
Study Summary
This randomized controlled trial is designed to evaluate whether a behavioral intervention that includes three components: 1) reminder letters and education materials delivered before the clinic visit, 2) telephone recalls after the visit for those who originally decline the vaccine, and 3) telephone reminders for those who miss the 2nd and/or 3rd doses, increases 1 and 3 dose coverage of the human papillomavirus (HPV) vaccine series among adolescent girls attending four Parkland primary care clinics in Dallas county. Hypothesis 1: Investigators expect higher 1 dose HPV vaccine coverage among patients in the Intervention group than those in the General Adolescent Vaccine Brochure group. Hypothesis 2: Investigators expect significantly higher 1 dose HPV vaccine coverage among patients in the Intervention group who initially declined the vaccine than those in the General Adolescent Vaccine Brochure group who initially declined. Hypothesis 3: Investigators expect significantly higher 3 dose HPV vaccine coverage among the Intervention group than those in the General Adolescent Vaccine Brochure group.
Primary Outcome
Receipt of 1 or more doses of the HPV vaccine during 12-month study period
Interventions
- BEHAVIORAL HPV brochure, recall, reminders
- BEHAVIORAL General Adolescent Vaccine Brochure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 831 participants |
| Start Date | 2010-05 |
| Est. Completion | 2012-11 |
| Phase | NA |
What the finished NCT01729429 record still lists
NCT01729429 is an interventional study that assigns participants to a tested intervention. The registered 831 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (41% lower).
The record links to 0 conditions, and to 2 interventions - of which HPV brochure, recall, reminders is the first listed.
NCT01729429 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01729429 about?
NCT01729429 is a clinical study titled "An Intervention Promoting HPV Vaccination in Safety-net Clinics". This randomized controlled trial is designed to evaluate whether a behavioral intervention that includes three components: 1) reminder letters and education materials delivered before the clinic visit, 2) telephone recalls after the visit for those who originally decline the vaccine, and 3) telephon...
What is the current status of trial NCT01729429?
This trial is currently completed. It is a NA study. The enrollment target is 831 participants. The study started on 2010-05. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01729429?
The interventions under investigation include: HPV brochure, recall, reminders (BEHAVIORAL), General Adolescent Vaccine Brochure (BEHAVIORAL).
Who is sponsoring clinical trial NCT01729429?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01729429's enrollment target sits among peer trials
831 134th of 2000 higher than 1,867 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06910553 · 832 participants
IBD Pregnancy Registry
- NCT07089706 · 832 participants · Phase 4
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
- NCT05067283 · 830 participants · Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- NCT06592924 · 830 participants · Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia